Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy

Circulation Research

Volumn 77, Issue 2, 1995, Pages 258-265

  Yamazaki, Tsutomu ^a   Komuro, Issei ^a   Kudoh, Sumiyo ^a   Zou, Yunzeng ^a   Shiojima, Ichiro ^a   Mizuno, Takehiko ^a   Takano, Hiroyuki ^a   Hiroi, Yukio ^a   Ueki, Kohjiro ^a   Tobe, Kazuyuki ^a   Kadowaki, Takashi ^a   Nagai, Ryozo ^a   Yazaki, Yoshio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

CV 11974; MAP kinase; saralasin; signal transduction

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 ETHOXY 1 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YL] 1H BENZIMIDAZOLE 7 CARBOXYLIC ACID; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN RECEPTOR; CANDESARTAN; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLALANINE; RECEPTOR SUBTYPE; SARALASIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MECHANICAL STRESS; MUSCLE STRETCHING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

EID: 0029117515     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.77.2.258     Document Type: Article

References (42)

1. Zak R. Factors controlling cardiac growth. In: Zak R, ed. Growth of the Heart in Health and Disease. New York, NY: Raven Press; 1984:165-185.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990; 322:1561-1566.
3. Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol. 1993;55:55-75.
4. Komuro I, Kaida T, Shibazaki Y, Kurabayashi M, Takaku F, Yazaki Y. Stretching cardiac myocytes stimulates proto-oncogene expression. J Biol Chem. 1990;265:3595-3598.
5. Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, Takaku F, Yazaki Y. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. J Biol Chem. 1991;266:1265-1268.
6. Yamazaki T, Tobe K, Hoh E, Maemura K, Kaida T, Komuro I, Tamemoto H, Kadowaki T, Nagai R, Yazaki Y. Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem. 1993;268:12069-12076.
7. Sei CA, Irons CE, Sprenkle AB, McDonough PM, Brown JH, Glembotski CC. The alpha-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways. J Biol Chem. 1991;266:15910-15916.
8. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. J Biol Chem. 1994;269:1110-1119.
9. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54:227-241.
10. Lindpaintner K, Ganten D. The cardiac renin-angiotensin system: an appraisal of present experimental and clinical evidence. Circ Res. 1991;68:905-921.
11. Baker KM, Singer HA, Aceto JF. Angiotensin II receptor-mediated Stimulation of cytosolic-free calcium and inositol phosphates in chick myocytes. J Pharmacol Exp Ther. 1989;251:578-585.
12. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res. 1993;73:424-438.
13. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effect on coronary resistance, contractility, and relaxation. J Clin Invest. 1990;86:1913-1920.
14. Linz W, Schoelkens BA, Ganten D. Converting enzyme inhibitor specifically prevents development and induces the regression of cardiac hypertrophy in rats. Clin Exp Hypertens. 1989;11:1325-1350.
15. Baker KM, Cherin MI, Wixon SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990;259:H324-H332.
16. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
17. Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Y, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation. 1994;89:2204-2211.
18. Simpson P, Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Circ Res. 1982;50:101-116.
19. Crews CM, Alessandrini A, Erikson RL. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science. 1992;258:478-480.
20. Pages G, Lenormand P, L'Allemain G, Chambard J-C, Meloche S, Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A. 1993;90:8319-8323.
21. Cowley S, Paterson H, Kemp P, Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 1994;77:841-852.
22. Ahn NG, Seger R, Bratlien RL, Diltz CD, Tonks NK, Krebs EG. Multiple components in an EGF-stimulated protein kinase cascade: in vitro activation of a MBP/MAP2 kinase. J Biol Chem. 1991;266: 4220-4227.
23. Tobe K, Kadowaki T, Hara K, Gotoh Y, Kosako H, Matsuda S, Tamemoto H, Ueki K, Akanuma Y, Nishida E, Yazaki Y. Sequential activation of MAP kinase activator, MAP kinases, and S6 peptide kinase in intact rat liver following insulin injection. J Biol Chem. 1992;267:21089-21097.
24. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF. Non-peptide angiotensin II receptor antagonists. Trends Pharmacol Sci. 1991;12:55-61.
25. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991;351:230-233.
26. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
27. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 1993;268:24539-24542.
28. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543-24546.
29. Nishida E, Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 1993; 18: 128-131.
30. Kyriakis JM, App H, Zhang X, Banerjee P, Brautigan DL, Rapp UR, Avruch J. Raf-1 activates MAP kinase-kinase. Nature. 1992; 358:417-421.
31. Dent P, Haser W, Haystead TAJ, Vincent LA, Roberts TM, Sturgill TW. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science. 1992;257:1404-1407.
32. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P, Marshall CJ. Activation of the MAP kinase pathway by the protein kinase raf. Cell. 1992;71:335-342.
33. Lange-Carter CA, Pleiman AM, Blumer KJ, Johnson GL. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science. 1993;260:315-319.
34. Lazou A, Bogoyevitch MA, Clerk A, Fuller SJ, Marshall CJ, Sugden PH. Regulation of mitogen-activated protein kinase cascade in adult rat heart preparation in vitro. Circ Res. 1994;75: 932-941.
35. Sen S, Tarazi RC, Khairallah PA, Bumpus FM. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res. 1974;35:775-781.
36. Frohlich ED, Tarazi RC. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol. 1979;44:959-963.
37. Dunn FG, Oigman W, Ventura HO, Messeri FH, Kobrin I, Frohlich ED. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol. 1984;53:105-108.
38. Sigurdson W, Ruknudin A, Sachs F. Calcium imaging of mechanically induced fluxes in tissue-cultured chick heart: role of stretchactivated ion channels. Am J Physiol. 1992;262:H1110-H1115.
39. Komuro I, Katoh Y, Hoh E, Takaku F, Yazaki Y. Mechanisms of cardiac hypertrophy and injury: possible role of protein kinase C activation. Jpn Circ J. 1991;55:1149-1157.
40. Komuro I, Yazaki Y. Intracellular signaling pathways in cardiac myocytes induced by mechanical stress. Trends Cardiovasc Med. 1994;4:117-121.
41. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature. 1993;364: 249-252.
42. Ueki K, Matsuda S, Tobe K, Gotoh Y, Tamemoto H, Yachi M, Akanuma Y, Yazaki Y, Nishida E, Kadowaki T. Feedback regulation of mitogen-activated protein kinase kinase activity of c-Raf-1 insulin and phorbol ester stimulation. J Biol Chem. 1994;269: 15756-15761.